Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib + Ipilimumab in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Immunotherapy in Rare Cancers Under InvesTigation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
FLX475 in Combination With Ipilimumab in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2